Market Place
Sourcing Support
Biocon Gets US FDA Nod For Liraglutide Injection Saxenda
25 Feb 2026 //
EXPRESSPHARMA
Kiran Mazumdar-Shaw Receives Honorary Fellowship From UK Academy
24 Feb 2026 //
EXPRESSPHARMA
Biocon Pharma’s Generics Liraglutide Receives Approval in US
24 Feb 2026 //
FDA
Bahiafarma, Biocon, Bionovis Inks Mou In Pharma Sector
21 Feb 2026 //
ECONOMICTIMES
Biocon Targets Growth With Generic Weight-Loss Drugs
13 Feb 2026 //
REUTERS
Biocon`s Shaw: Budget Boosts India`s Health, Innovation
01 Feb 2026 //
ECONOMICTIMES
Biocon Biologics Gets Credit Boost From S&P, Outlook Stable
30 Jan 2026 //
INDPHARMAPOST
Biocon Completes Rs. 4,150 Crore Equity Fundraise Through QIP
15 Jan 2026 //
INDPHARMAPOST
Biocon Arm Gets USFDA Nod For Generic Everolimus Tablets
12 Jan 2026 //
ECONOMICTIMES
Biocon Pharma’s Generics Everolimus Receives Approval in US
09 Jan 2026 //
FDA
Biocon Signs Out-Licensing Deal For Semaglutide With Ajanta
23 Dec 2025 //
INDPHARMAPOST
Biocon Launches Liraglutide for Diabetes, Obesity in India
15 Dec 2025 //
EXPRESSPHARMA
USC India Honors Kiran Mazumdar-Shaw with Top Business Award
10 Dec 2025 //
EXPRESSPHARMA
Biocon To Merge Biocon Biologics In $5.5 Billion Deal
06 Dec 2025 //
REUTERS
Bion’s Generics Carbidopa Receives Tentative Approval in US
04 Dec 2025 //
FDA
Biocon Biologics Settles With Amgen For Denosumab Biosimilars
02 Dec 2025 //
EXPRESSPHARMA
Biocon Pharma Gets FDA Nod For Arthritis Drug Tofacitinib ER
23 Nov 2025 //
INDPHARMAPOST
Kiran Mazumdar-Shaw Ranked 2Nd Most Generous Woman By Hurun India
21 Nov 2025 //
INDPHARMAPOST
Biocon Stands Out Globally As Biosimilars Leader: Kiran
21 Nov 2025 //
ECONOMICTIMES
Biocon’s Generics Tofacitinib Receives Tentative Approval in US
17 Nov 2025 //
FDA
Biocon Considers Merging Biocon Biologics in $4.5 Billion Deal
13 Nov 2025 //
ECONOMICTIMES
Biocon Gets 1 USFDA Observation For Cranbury Site
14 Oct 2025 //
INDPHARMAPOST
Biocon Unit Gets USFDA Nod For Genetic Anti-Bacterial Drug
07 Oct 2025 //
ECONOMICTIMES
Biocon Foundation Constructs High School Building in Karnataka
14 Sep 2025 //
INDPHARMAPOST
Biocon Opens First US Manufacturing Facility in Cranbury, NJ
10 Sep 2025 //
PR NEWSWIRE
Groups Demand Better Review Practices, Transparency in PDUFA VIII
20 Aug 2025 //
RAPS
Biocon Q1 FY26 PAT Drops 95% to Rs. 31.4 Cr
08 Aug 2025 //
INDPHARMAPOST
Biocon Foundation, IISc Mark World Head & Neck Cancer Day
29 Jul 2025 //
INDPHARMAPOST
Deepali Appointed as Biocon` Corporate Communications Head
23 Jul 2025 //
EXPRESSPHARMA
Biocon Aims to Launch Generic Wegovy in India by 2027, Says CEO
16 Jul 2025 //
ECONOMICTIMES
Biocon Targets Canadian Market with Ozempic, Wegovy Generics
02 Jul 2025 //
ECONOMICTIMES
Biocon Foundation launches BioWISE Program for Women in STEM
11 Jun 2025 //
INDPHARMAPOST
Biocon Gets Approval for Diabetes Drug Liraglutide in India
02 Jun 2025 //
INDPHARMAPOST
Biocon`s Generics Rivaroxaban Receives Approval in US
14 May 2025 //
FDA
Biocon Q4 FY25 consolidated PAT jumps 153% to Rs. 344 Cr
14 May 2025 //
INDPHARMAPOST
Indian pharma stocks decline after Trump again threatens tariffs
09 Apr 2025 //
REUTERS
Biocon Academy conducts its 9th Graduation Day
04 Mar 2025 //
EXPRESSPHARMA
Biocon betting big on new product launches for growth
13 Feb 2025 //
ECONOMICTIMES
Biocon posts Q3 FY25 PAT at Rs. 25 Cr
31 Jan 2025 //
INDPHARMAPOST
Biocon`s Generics Dasatinib Receive Tentative Approval in US
17 Jan 2025 //
FDA
Bicon`s Generics Oxcarbazepine Receives Tentative Approval in US
08 Jan 2025 //
FDA
Biocon accused of IP theft to create cancer biotech Bicara
24 Oct 2024 //
FIERCE BIOTECH
Biocon Report Explores Pathways To Increase Biosimilar Adoption
09 Oct 2024 //
EXPRESSPHARMA
FDA Issues Form 483 to Biocon Sdn.
07 Oct 2024 //
FDA
Biocon unit gets USFDA nod for generic drug
02 Sep 2024 //
ECONOMICTIMES
Biocon`s Generics Sacubitril; Valsartan Receives Approval in US
30 Aug 2024 //
FDA
Biocon`s Generics Daptomycin Receives Approval in US
29 Aug 2024 //
FDA
Biocon Settles With Janssen To Sell Biosimilars In Multiple Regions
29 Aug 2024 //
CONTRACT PHARMA
Biocon arm`s growth formula: US rollouts & debt reduction
12 Aug 2024 //
ECONOMICTIMES
Biocon posts Q1 FY25 PAT higher at Rs. 660 Cr
11 Aug 2024 //
INDIANPHARMAPOST
USFDA observations for Biocon Biologics unit. Details here
08 Aug 2024 //
CNBCTV18
India`s Biocon posts Q1 profit rise on sale of branded formulations business
08 Aug 2024 //
REUTERS
Biocon`s Generics Lenalidomide Receives Tentative Approval in US
02 Aug 2024 //
FDA
Biocon Foundation And IISc Lead AI-Center Of Excellence Project
30 Jul 2024 //
PHARMABIZ
USFDA completes inspection at Biocon Biologics’ facilities in Bengaluru
29 Jul 2024 //
INDIANPHARMAPOST
Biocon Gets 4 Observations From USFDA For Andhra Pradesh Facility
22 Jun 2024 //
ECONOMICTIMES
Biocon seeks partner to test generic Wegovy, Ozempic in China
21 Jun 2024 //
MONEYCONTROL
Biocon inks licensing, supply pact Handok for chronic weight management product
24 May 2024 //
PRESS RELEASE
US FDA approves two biosimilars for blockbuster eye drug Eylea
21 May 2024 //
REUTERS
Acceleration of biosimilar business, debt reduction priorties in FY25: Biocon
18 May 2024 //
ECONOMICTIMES
